Small-Molecule Inhibitors and Degraders Targeting KRAS-Driven Cancers

Drug resistance continues to be a major problem associated with cancer treatment. One of the primary causes of anticancer drug resistance is the frequently mutated RAS gene. In particular, considerable efforts have been made to treat KRAS-induced cancers by directly and indirectly controlling the ac...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Soonsil Hyun, Dongyun Shin
Formato: article
Lenguaje:EN
Publicado: MDPI AG 2021
Materias:
RAS
Acceso en línea:https://doaj.org/article/69812bda3185416abd49d119a6d7fd35
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares